Australia: A recent study published in Clinical Infectious Diseases has shown that the current use of integrase strand ...

Dolutegravir is an HIV integrase strand transfer inhibitor (INSTI) that does not require pharmacokinetic boosting, has a long half-life allowing for once-daily dosing in treatment-naive patients ...

A new WHO report sheds light on the latest advancements in optimizing second- and third-line HIV treatment. The comprehensive ...

Antiretroviral therapy is used to treat HIV and is comprised of a combination of drugs that block different stages in the virus' replication cycle. By doing so, the virus can be suppressed to ...

Taking Truvada with certain protease inhibitor medications can raise your ... may cause atazanavir not to work as well in treating HIV-1. This means that atazanavir may not stop the virus in ...

Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, New Jersey 08854, United States Center for Advanced Biotechnology and ...

By 1996, a new class of drugs called protease inhibitors had been approved for the treatment of HIV. The drugs prevent new HIV from maturing and infecting healthy cells. They "changed everything ...

The committee found that at the start of the trial the researchers had no specific evidence that would indicate that DMF was either a protease inhibitor or that it would inhibit HIV in a clinical ...

The Mexican Social Security Institute (IMSS), the United Nations Population Fund (UNFPA) and the México Vivo Foundation.

Kidney transplantation from donors with human immunodeficiency virus (HIV) to recipients with HIV is an emerging practice. It has been performed since 2016 under the U.S. congressional HIV Organ ...